Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVPS: Gemcitabine, Vincristine, and Cisplatin for Sarcoma
NCT01192633Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jan 2009
- Primary completion
- Jan 2011
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, vincristine sulfate liposome injection, Cisplatin micelle injection (HA132) in sarcoma, sponsored by Fudan University. Status: unknown.
02
Drugs
gemcitabinevincristine sulfate liposome injectionCisplatin micelle injection (HA132)
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT01192633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192633.